百花医药：上半年归母净利润同比增长12.45%

Group 1 - The core viewpoint of the article is that Baihua Pharmaceutical announced its financial results for the first half of 2025, showing a modest growth in revenue and net profit [1] Group 2 - Baihua Pharmaceutical reported an operating income of 202 million yuan for the first half of 2025, representing a year-on-year increase of 2.95% [1] - The company's net profit attributable to shareholders reached 25.48 million yuan, reflecting a year-on-year growth of 12.45% [1]